CorMedix Inc. CRMD
Slide the table for earlier years · "·" marks a figure not available in our data for that year.
Growth
Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.
Profitability
Each USD of equity produced 67 cents of profit this year.
The 19-year record
EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue $B | 0.3 | 0.0 | ◌ | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ◌ | ◌ | ◌ | ◌ | ◌ |
| Operating income $B | 0.2 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | ◌ | ◌ | ◌ |
| EBITDA $B | 0.2 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | ◌ | ◌ | ◌ |
| Income tax $B | −0.0 | −0.0 | ◌ | −0.0 | −0.0 | −0.0 | −0.0 | ◌ | ◌ | ◌ | ◌ | ◌ | 0.0 | 0.0 | −0.0 | −0.0 | ◌ | ◌ | ◌ |
| Net income $B | 0.2 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 |
| Free cash flow $B | 0.2 | −0.1 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | ◌ | ◌ | ◌ |
| EPS, diluted $ | 2.04 | −0.30 | −0.91 | −0.74 | −0.75 | −0.77 | −1.80 | −1.51 | −0.60 | −0.65 | −0.58 | −0.96 | −0.69 | −0.30 | −0.58 | −1.15 | ◌ | ◌ | ◌ |
| Dividend / sh $ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ |
| Payout % — not applicable: no dividend | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ROE % | 66.6 | −23.2 | −74.0 | −50.4 | −52.7 | −64.9 | −115.0 | −442.5 | −264.0 | −95.1 | −96.6 | — | — | — | −155.4 | — | — | — | — |
| Shares out B | 0.08 | 0.06 | 0.05 | 0.04 | 0.04 | 0.03 | 0.03 | 0.11 | 0.07 | 0.04 | 0.04 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | ◌ | ◌ | ◌ |
Slide the table for earlier years. "—" not applicable · "◌" not available in our data.
Company facts, as filed
Reconciled in 15 of the 19 fiscal years we could check. 4 of those reconciliations are divergences — the figures exist but don't fit the formula this check expects; that isn't the same as an error. Six checks were skipped: the balance sheet is not tagged before 2010. Five checks were skipped: revenue is not tagged before 2012. Four checks were skipped: the share count is not tagged before 2011.